Impact BioMedical Inc [IBO] stock prices are down -18.26% to $0.75 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IBO shares have gain 107.68% over the last week, with a monthly amount glided 36.73%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Impact BioMedical Inc [IBO] has been fluctuating between $0.36 and $6.17 over the past year. Impact BioMedical Inc [AMEX: IBO] shares were valued at $0.75 at the most recent close of the market.
Analyzing the IBO fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.46%, Pretax Profit Margin comes in at -9.8%, and Net Profit Margin reading is -9.8%. To continue investigating profitability, this company’s Return on Assets is posted at -1.66, Equity is -3.05 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6417 points at the first support level, and at 0.5315 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9046, and for the 2nd resistance point, it is at 1.0573.
Ratios To Look Out For
It’s worth pointing out that Impact BioMedical Inc [AMEX:IBO]’s Current Ratio is 0.22. As well, the Quick Ratio is 0.17, while the Cash Ratio is 1.14.
Transactions by insiders
Recent insider trading involved DSS, INC., 10% Owner, that happened on May 22 ’25 when 0.12 million shares were sold. 10% Owner, DSS, INC. completed a deal on May 27 ’25 to sell 45400.0 shares. Meanwhile, 10% Owner DSS, INC. sold 0.89 million shares on Apr 04 ’25.
